These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 9760378)

  • 1. Better medication compliance in teenagers with ADHD.
    J Psychosoc Nurs Ment Health Serv; 1998 Sep; 36(9):9-10. PubMed ID: 9760378
    [No Abstract]   [Full Text] [Related]  

  • 2. Rates of adherence to pharmacological treatment among children and adolescents with attention deficit hyperactivity disorder.
    Ibrahim el SR
    Hum Psychopharmacol; 2002 Jul; 17(5):225-31. PubMed ID: 12404679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2005 Sep; 54(34):842-7. PubMed ID: 16138075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compliance with guidelines for ADHD: a pilot study of an evaluation tool.
    Vreeman RC; Madsen KA; Vreeman DJ; Carroll AE; Downs SM
    J Pediatr; 2006 Oct; 149(4):568-71. PubMed ID: 17011336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder: advances in diagnostic and therapeutic approaches.
    DelBello MP
    J Clin Psychiatry; 2008 Jan; 69(1):130. PubMed ID: 18312047
    [No Abstract]   [Full Text] [Related]  

  • 7. Overweight in children and adolescents in relation to attention-deficit/hyperactivity disorder: results from a national sample.
    Waring ME; Lapane KL
    Pediatrics; 2008 Jul; 122(1):e1-6. PubMed ID: 18595954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sociodemographic and clinical factors associated with compliance to methylphenidate treatment in children with attention deficit hyperactivity disorder].
    Kiliç BG; Bilgiç A; Gürkan K; Aysev A
    Turk Psikiyatri Derg; 2007; 18(3):207-13. PubMed ID: 17853975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
    Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns and predictors of medication compliance, diversion, and misuse in adult prescribed methylphenidate users.
    Darredeau C; Barrett SP; Jardin B; Pihl RO
    Hum Psychopharmacol; 2007 Dec; 22(8):529-36. PubMed ID: 17910020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parental angst making and revisiting decisions about treatment of attention-deficit/hyperactivity disorder.
    Brinkman WB; Sherman SN; Zmitrovich AR; Visscher MO; Crosby LE; Phelan KJ; Donovan EF
    Pediatrics; 2009 Aug; 124(2):580-9. PubMed ID: 19651580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Satisfaction with treatment for attention-deficit/hyperactivity disorder.
    Bukstein OG
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S107-16. PubMed ID: 15352537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medication adherence in psychopharmacologically treated adults with ADHD.
    Safren SA; Duran P; Yovel I; Perlman CA; Sprich S
    J Atten Disord; 2007 Feb; 10(3):257-60. PubMed ID: 17242421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view.
    Rowland AS; Lesesne CA; Abramowitz AJ
    Ment Retard Dev Disabil Res Rev; 2002; 8(3):162-70. PubMed ID: 12216060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit/hyperactivity disorder: medication treatment-dosing and duration of action.
    Steinhoff KW
    Am J Manag Care; 2004 Jul; 10(4 Suppl):S99-106. PubMed ID: 15352536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there placebo effects in the medication treatment of children with attention-deficit hyperactivity disorder?
    Waschbusch DA; Pelham WE; Waxmonsky J; Johnston C
    J Dev Behav Pediatr; 2009 Apr; 30(2):158-68. PubMed ID: 19363369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive changes related to medication treatment of ADHD: listening to parents of children in clinical trials of a novel nonstimulant medication.
    Saylor KE; Buermeyer CM; Spencer TJ; Barkley RA
    J Clin Psychiatry; 2002; 63 Suppl 12():23-8. PubMed ID: 12562058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.
    Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R
    J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
    Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
    Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.